Cyclin-dependent kinase (CDK) 4/6 inhibition in non-small cell lung cancer with epidermal growth factor receptor (EGFR) mutations Atsushi OsoegawaYohei TakumiKenji Sugio Research 15 February 2023 Pages: 183 - 192
In vitro effects of gamma-secretase inhibition in HPV-positive and HPV-negative head and neck squamous cell carcinoma Sara VaratanovicTobias MaierFaris F. Brkic Research Open access 21 February 2023 Pages: 193 - 201
Effective anticancer agents based-on two Pillar[5]arene derivatives for pancreas cancer cell lines: synthesis, apoptotic effect, caspase pathway Mehmet Ali KaraselekSerkan KuccukturkCelalettin Vatansev Research 11 March 2023 Pages: 202 - 209
Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines Hana DostálováRadek JordaVladimír Kryštof Research Open access 13 March 2023 Pages: 210 - 219
RNA silencing of GM-CSF in CAR-T cells reduces the secretion of multiple inflammatory cytokines Siqi ShangYunshuo ChenYueying Wang Research 29 March 2023 Pages: 220 - 225
Development of a MET-targeted single-chain antibody fragment as an anti-oncogene targeted therapy for breast cancer Rana VafaeiZohreh KhakiLeila Farahmand Research 01 April 2023 Pages: 226 - 239
Mesenchymal stem cells: a trojan horse to treat glioblastoma Antoine ChartouniAntoine MouawadHampig Raphaël Kourie Review 05 April 2023 Pages: 240 - 250
SLIT mutations as potential predictive biomarkers for immunotherapy in NSCLC Tong ZhouHuan YiTianyu Lu Correspondence 10 April 2023 Pages: 251 - 253
Iruplinalkib (WX‑0593), a novel ALK/ROS1 inhibitor, overcomes crizotinib resistance in preclinical models for non-small cell lung cancer Yingying YangQingmei ZhengShansong Zheng Research Open access 10 April 2023 Pages: 254 - 266
Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a study Markus JoergerThomas HundsbergerAnastasios Stathis Research Open access 16 February 2023 Pages: 267 - 275
Effect of a moderate CYP3A inducer efavirenz on the pharmacokinetics of fuzuloparib: An open-label, fixed sequence study in Chinese healthy male subjects Linlin HuTing DouHuiping Wang Research 17 February 2023 Pages: 276 - 283
Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ-PBMC-HPV) in HLA-A*02+ patients with HPV16+ solid tumors Antonio JimenoJoaquina BarandaArmon Sharei Research Open access 03 March 2023 Pages: 284 - 295
A phase I dose-escalation study of SYHA1813, a VEGFR and CSF1R inhibitor, in patients with recurrent High-Grade Gliomas or Advanced Solid Tumors Zhuang KangShenglan LiWenbin Li Research Open access 08 March 2023 Pages: 296 - 305
Evaluation of combination treatment with DS-1205c, an AXL kinase inhibitor, and osimertinib in metastatic or unresectable EGFR-mutant non-small cell lung cancer: results from a multicenter, open-label phase 1 study James Chih-Hsin YangWu-Chou SuGee-Chen Chang Research Open access 09 March 2023 Pages: 306 - 316
A tumor-selective adenoviral vector platform induces transient antiphospholipid antibodies, without increased risk of thrombosis, in phase 1 clinical studies Danny N. KhalilIsabel Prieto González-AlboGerald A. Soff Brief Report 10 March 2023 Pages: 317 - 323
A phase 1b study of the allosteric extracellular FGFR2 inhibitor alofanib in patients with pretreated advanced gastric cancer Ilya TsimafeyeuGalina StatsenkoSergei Tjulandin Research 13 March 2023 Pages: 324 - 332
Clinical characteristics, treatment and outcome of nivolumab-induced myasthenia gravis Chunjiang WangHanqing ZengLiying Song Research 29 March 2023 Pages: 333 - 339
Effects on survival of the adverse event of atezolizumab plus bevacizumab for hepatocellular carcinoma: a multicenter study by the Japan Red Cross Liver Study Group Shintaro TakakiMasayuki KurosakiNamiki Izumi Research 30 March 2023 Pages: 340 - 349
Complete Response to tenalisib and romidepsin with long-term maintenance using tenalisib monotherapy in a patient with relapsed and refractory sézary syndrome Christopher N. NguyenSwaminathan P. IyerAuris O. Huen Case Report 01 April 2023 Pages: 350 - 355
Immunohistochemical analysis of B7-H3 expression in patients with lung cancer following various anti-cancer treatments Shota OmoriKoji MuramatsuToshiaki Takahashi Research 10 April 2023 Pages: 356 - 364